🦊/Lists

Biotech Investors & VC Firms in Europe

841 firms in this list, with a median first check of $500K. 192 of them lead rounds. Generated from verified public data and updated continuously.

Korea Investment Partners
SeoulSeed–Late Stage$973K – $50M
17 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
Chartered Group
TokyoSeed
22 people
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
IDG Capital
Hong KongPre-Seed–Late Stage$3M – $200M
6 people
Fast Track Initiative
TokyoPre-Seed–Growth$1.2M – $184M
2 people
OMX Ventures
LincolnshireSeed–Series A
10 people
AbbVie
CambridgeSeed–Late Stage$300K – $3M
13 people
AMR Action Fund
BostonSeed–Series C
14 people
Pivotal Life Sciences
San FranciscoSeed–Late Stage
14 people
Forward Venture Capital
DenverPre-Seed–Series A$50K – $500K
2 people
Clay Capital
Seed–Late Stage$3M – $8M
16 people
Kinled Holding
Hong KongSeed–Series A
1 person
Supermoon Capital
San FranciscoPre-Seed–Series A$150K – $2.5M
7 people
Maxpro Ventures
TaipeiSeed–Late Stage$10M – $13M
7 people
AIR Capital
Buenos AiresPre-Seed–Series A
2 people
Magnetic Ventures
BostonSeed–Series A$1M – $6M
9 people
MC Healthcare Ventures
CambridgeSeed–Series A
6 people
New Rhein Healthcare Investors, LLC
PhiladelphiaSeries A–Late Stage
15 people
RTW Investments L.P.
New YorkSeed–Series A
14 people
Diamond Edge Ventures
San FranciscoSeed–Series A
13 people
Cross-Border Impact Ventures
TorontoSeries A–Series B$2M – $10M
12 people
Propel Bio Partners
Los AngelesSeed–Series A
17 people
Fine Structures Ventures
CambridgePre-Seed–Late Stage
10 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.